Page last updated: 2024-10-16

ammonium hydroxide and Autosomal Dominant Juvenile Parkinson Disease

ammonium hydroxide has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.

Research Excerpts

ExcerptRelevanceReference
"An atypical form of parkinsonism has been described in patients with chronic liver disease, associated with increased T1 signal in the basal ganglia on magnetic resonance imaging."1.33Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. ( Ahlskog, JE; Cowl, CT; Fealey, RD; Josephs, KA; Klos, KJ; Kumar, N, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kok, B1
Foxton, MR1
Clough, C1
Shawcross, DL1
Klos, KJ1
Ahlskog, JE1
Josephs, KA1
Fealey, RD1
Cowl, CT1
Kumar, N1

Other Studies

2 other studies available for ammonium hydroxide and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy.
    Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:4

    Topics: Aged; Ammonia; Anti-Infective Agents; Brain; Electroencephalography; Female; Hepatic Encephalopathy;

2013
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity.
    Archives of neurology, 2005, Volume: 62, Issue:9

    Topics: Adult; Aged; Ammonia; Basal Ganglia Diseases; Brain Chemistry; Cognition Disorders; Female; Gait Ata

2005